NovAccess Global Financials
| XSNX Stock | USD 0.01 0 80.00% |
NovAccess |
Understanding current and past NovAccess Global Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of NovAccess Global's financial statements are interrelated, with each one affecting the others. For example, an increase in NovAccess Global's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in NovAccess Global's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of NovAccess Global. Check NovAccess Global's Beneish M Score to see the likelihood of NovAccess Global's management manipulating its earnings.
NovAccess Global Stock Summary
NovAccess Global competes with Adagene. NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio. Novaccess Global operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US67001N1072 |
| Business Address | 8834 Mayfield Road, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | novaccessglobal.com |
| Phone | 440 644 1027 |
| Currency | USD - US Dollar |
NovAccess Global Key Financial Ratios
NovAccess Global's financial ratios allow both analysts and investors to convert raw data from NovAccess Global's financial statements into concise, actionable information that can be used to evaluate the performance of NovAccess Global over time and compare it to other companies across industries.| Return On Asset | -5.13 | |||
| Beta | 1.55 |
NovAccess Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NovAccess Global's current stock value. Our valuation model uses many indicators to compare NovAccess Global value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NovAccess Global competition to find correlations between indicators driving NovAccess Global's intrinsic value. More Info.NovAccess Global is rated second in return on asset category among its peers. It is rated second in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value NovAccess Global by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for NovAccess Global's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.NovAccess Global Systematic Risk
NovAccess Global's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. NovAccess Global volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on NovAccess Global correlated with the market. If Beta is less than 0 NovAccess Global generally moves in the opposite direction as compared to the market. If NovAccess Global Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one NovAccess Global is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of NovAccess Global is generally in the same direction as the market. If Beta > 1 NovAccess Global moves generally in the same direction as, but more than the movement of the benchmark.
NovAccess Global December 4, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of NovAccess Global help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NovAccess Global. We use our internally-developed statistical techniques to arrive at the intrinsic value of NovAccess Global based on widely used predictive technical indicators. In general, we focus on analyzing NovAccess Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NovAccess Global's daily price indicators and compare them against related drivers.
| Downside Deviation | 26.81 | |||
| Information Ratio | 0.1119 | |||
| Maximum Drawdown | 206.94 | |||
| Value At Risk | (31.43) | |||
| Potential Upside | 44.0 |
Additional Tools for NovAccess Pink Sheet Analysis
When running NovAccess Global's price analysis, check to measure NovAccess Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovAccess Global is operating at the current time. Most of NovAccess Global's value examination focuses on studying past and present price action to predict the probability of NovAccess Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovAccess Global's price. Additionally, you may evaluate how the addition of NovAccess Global to your portfolios can decrease your overall portfolio volatility.